MedPath
NMPA Approval

Liraglutide Injection

国药准字SJ20160004

March 3, 2025

S20160004

Drug Information

利拉鲁肽注射液

诺和力

注射剂

3ml:18mg(预填充注射笔)

生物制品

March 3, 2025

March 2, 2030

Company Information

Applicant Company

Novo Nordisk A/S

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Novo Nordisk A/S

Novo Alle, DK-2880 Bagsvaerd, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.